Biocon Biologics to Acquire Viatris’ Biosimilars Assets For $ 3.335 Billion
▪ Biocon Biologics Limited’s (BBL) acquisition of Viatris’ rights in biosimilars assets,…
Syngene Expands Biopharma-manufacturing Capacity
Bengaluru, NFAPost: Syngene International, an integrated research, development and cGMP manufacturing services…
Biocon Partners With Adagio To Manufacture Novel Antibody For Treatment Of Covid-19
Biocon Biologics to manufacture and commercialise a broadly neutralising antibody for India…
Covid Has Created An Ecosystem Of Innovation In India: Kiran Mazumdar-Shaw
The ongoing Covid-19 public health crisis has resulted in the creation of…
Biocon Biologics partners with Voluntis for digital therapeutics for diabetes patients
Amritsar, NFAPost: Biocon Biologics has announced a global collaboration agreement with Voluntis…
Biocon’s psoriaris injection okayed for emergency use on Covid-19 patients; Co to launch drug at 8,000 rupees per vial
Amritsar, NFAPost: Biocon Ltd’s Itolizumab, a drug used to cure skin ailment…
